1. J Med Genet. 2017 Jun;54(6):371-380. doi: 10.1136/jmedgenet-2016-104436. Epub 
2017 Mar 13.

Fifteen years of research on oral-facial-digital syndromes: from 1 to 16 causal 
genes.

Bruel AL(1)(2), Franco B(3)(4), Duffourd Y(1)(2), Thevenon J(1)(2)(5), Jego 
L(1)(2), Lopez E(2), Deleuze JF(6), Doummar D(7), Giles RH(8), Johnson CA(9), 
Huynen MA(10), Chevrier V(11)(12)(13)(14), Burglen L(7), Morleo M(2)(3), 
Desguerres I(15), Pierquin G(16), Doray B(17), Gilbert-Dussardier B(18), 
Reversade B(19), Steichen-Gersdorf E(20), Baumann C(21), Panigrahi I(22), 
Fargeot-Espaliat A(23), Dieux A(24), David A(25), Goldenberg A(26), Bongers 
E(27), Gaillard D(28), Argente J(29)(30)(31), Aral B(32), Gigot N(1)(2)(32), 
St-Onge J(1)(2), Birnbaum D(11)(12)(13)(14), Phadke SR(33), Cormier-Daire 
V(3)(34)(35), Eguether T(36), Pazour GJ(36), Herranz-Pérez V(37)(38), Goldstein 
JS(39), Pasquier L(40), Loget P(41), Saunier S(42)(43), Mégarbané A(44), Rosnet 
O(11)(12)(13)(14), Leroux MR(45)(46), Wallingford JB(47)(48), Blacque OE(49), 
Nachury MV(39), Attie-Bitach T(34)(35)(43), Rivière JB(1)(2)(32), Faivre 
L(1)(2)(5), Thauvin-Robinet C(1)(2)(5).

Author information:
(1)FHU-TRANSLAD, Université de Bourgogne/CHU Dijon, Dijon, France.
(2)Équipe EA42271 GAD, Université de Bourgogne, Dijon, France.
(3)Department of Translational Medicine, Medical Genetics Ferderico II 
University of Naples, Naples, Italy.
(4)Telethon Institute of Genetics and Medicine-TIGEM, Naples, Italy.
(5)Centre de Référence maladies rares « Anomalies du Développement et syndrome 
malformatifs » de l'Est et Centre de Génétique, Hôpital d'Enfants, CHU, Dijon, 
France.
(6)Centre National de Génotypage, Evry, France.
(7)APHP, hôpital TROUSSEAU, Centre de référence des malformations et maladies 
congénitales du cervelet et département de génétique, Paris, France.
(8)Department of Nephrology and Hypertension, University Medical Center Utrecht, 
Utrecht, The Netherlands.
(9)Section of Ophthalmology and Neurosciences, Leeds Institute of Molecular 
Medicine, University of Leeds, Leeds, UK.
(10)Centre for Molecular and Biomolecular Informatics, Radboud Institute for 
Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The 
Netherlands.
(11)Centre de Recherche en Cancérologie de Marseille, Marseille, France.
(12)Institut Paoli-Calmettes, Marseille, France.
(13)CNRS U7258, Marseille, France.
(14)Aix-Marseille Université, Marseille, France.
(15)Service de neurométabolisme, Hôpital Necker-Enfants Malades, CHU, Paris, 
France.
(16)Service de Génétique, CHU, Liège, Belgium.
(17)Service de Génétique Médicale, Hôpital de Hautepierre, CHU, Strasbourg, 
France.
(18)Centre de Référence Maladies Rares, Université de Poitiers, Poitiers, 
France.
(19)Laboratory of Human Embryology and Genetics, Institute of Medical Biology, 
Singapore.
(20)Department of Pediatrics I, Innsbruck Medical University, Innsbruck, 
Austria.
(21)Département de Génétique, Unité Fonctionelle de Génétique Clinique, Hôpital 
Robert Debré, CHU, Paris, France.
(22)Genetic-Metabolic Unit, Department of Pediatrics, Advanced Pediatric Centre, 
PGIMER, Chandigarh, India.
(23)Pédiatrie Neonatalogie, Centre Hospitalier Général, Brive-la-Gaillarde, 
Brive-la-Gaillarde, France.
(24)Centre de Référence CLAD NdF, Service de Génétique Clinique, Hôpital Jeanne 
de Flandre, CHRU, Lille, France.
(25)Service de Génétique Médicale, Unité de Génétique Clinique, Hôpital 
Mère-Enfant, CHU, Nantes, France.
(26)Service de Génétique, CHU de Rouen, Centre Normand de Génomique Médicale et 
Médecine Personnalisée, Rouen, France.
(27)Department of Human Genetics, Radboud University, Nijmegen, The Netherlands.
(28)Service de Génétique, Hôpital Maison Blanche, CHRU, Reims, France.
(29)Department of Pediatrics & Pediatric Endocrinology, Hospital Infantil 
Universitario Niño Jesús, Madrid, Spain.
(30)Department of Pediatrics, Universidad Autónoma de Madrid, Madrid, Spain.
(31)CIBEROBN de fisiopatología de la obesidad y nutrición, Instituto de Salud 
Carlos III, Madrid, Spain.
(32)Laboratoire de Génétique Moléculaire, PTB, CHU, Dijon, France.
(33)Department of Medical Genetics, Sanjay Gandhi Post Graduate Institute of 
Medical Sciences, Lucknow, India.
(34)INSERM UMR1163, Université de Paris-Descartes-Sorbonne Paris Cité, Institut 
IMAGINE, Hôpital Necker-Enfants Malades, Paris, France.
(35)Service de génétique médicale, Hôpital Universitaire Necker-Enfants Malades, 
AP-HP, Institut Imagine, Paris, France.
(36)Program in Molecular Medicine, University of Massachusetts Medical School, 
Worcester, Massachusetts, USA.
(37)Laboratorio de Neurobiología Comparada, Instituto Cavanilles, Universitat de 
València, CIBERNED, Valencia, Spain.
(38)Unidad mixta de Esclerosis Múltiple y Neurorregeneración, IIS Hospital La 
Fe-UVEG, Valencia, Spain.
(39)Department of Molecular and Cellular Physiology, Stanford University School 
of Medicine, Stanford, California, USA.
(40)Centre de Référence Maladies Rares, Unité Fonctionnelle de Génétique 
Médicale, CHU, Rennes, France.
(41)Laboratoire d'Anatomie-Pathologie, CHU Rennes, Rennes, France.
(42)INSERM U983, Institut IMAGINE, Hôpital Necker-Enfants Malades, Paris, 
France.
(43)Département de Génétique, Hôpital Necker-Enfants Malades, AP-HP, Paris, 
France.
(44)Institut Jérôme Lejeune, Paris, France.
(45)Department of Molecular Biology and Biochemistry, Simon Fraser University, 
Burnaby, British Columbia, Canada.
(46)Centre for Cell Biology, Development and Disease, Simon Fraser University, 
Burnaby, British Columbia, Canada.
(47)Department of Molecular Biosciences, Center for Systems and Synthetic 
Biology, University of Texas at Austin, Austin, Texas, USA.
(48)Institute for Cellular and Molecular Biology, University of Texas at Austin, 
Austin, Texas, USA.
(49)School of Biomolecular and Biomedical Science, University College Dublin, 
Dublin, Ireland.

Oral-facial-digital syndromes (OFDS) gather rare genetic disorders characterised 
by facial, oral and digital abnormalities associated with a wide range of 
additional features (polycystic kidney disease, cerebral malformations and 
several others) to delineate a growing list of OFDS subtypes. The most frequent, 
OFD type I, is caused by a heterozygous mutation in the OFD1 gene encoding a 
centrosomal protein. The wide clinical heterogeneity of OFDS suggests the 
involvement of other ciliary genes. For 15 years, we have aimed to identify the 
molecular bases of OFDS. This effort has been greatly helped by the recent 
development of whole-exome sequencing (WES). Here, we present all our published 
and unpublished results for WES in 24 cases with OFDS. We identified causal 
variants in five new genes (C2CD3, TMEM107, INTU, KIAA0753 and IFT57) and 
related the clinical spectrum of four genes in other ciliopathies (C5orf42, 
TMEM138, TMEM231 and WDPCP) to OFDS. Mutations were also detected in two genes 
previously implicated in OFDS. Functional studies revealed the involvement of 
centriole elongation, transition zone and intraflagellar transport defects in 
OFDS, thus characterising three ciliary protein modules: the complex 
KIAA0753-FOPNL-OFD1, a regulator of centriole elongation; the Meckel-Gruber 
syndrome module, a major component of the transition zone; and the CPLANE 
complex necessary for IFT-A assembly. OFDS now appear to be a distinct subgroup 
of ciliopathies with wide heterogeneity, which makes the initial classification 
obsolete. A clinical classification restricted to the three 
frequent/well-delineated subtypes could be proposed, and for patients who do not 
fit one of these three main subtypes, a further classification could be based on 
the genotype.

© Article author(s) (or their employer(s) unless otherwise stated in the text of 
the article) 2017. All rights reserved. No commercial use is permitted unless 
otherwise expressly granted.

DOI: 10.1136/jmedgenet-2016-104436
PMCID: PMC5557276
PMID: 28289185 [Indexed for MEDLINE]

Conflict of interest statement: Competing interests: None declared.